SLNO - Company ID 0001484565
The table below shows SOLENO THERAPEUTICS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $70.11M | $87.93M | $169.68M | $14.60M | $21.30M | $49.22M |
| Short-term investments | $235.37M | $203.51M | - | - | - | - |
| Receivables | $28.21M | - | - | - | - | - |
| Inventory | $15.02M | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $355.81M |
| $293.89M |
| $171.36M |
| $15.65M |
| $22.42M |
| $50.24M |
| Property, plant & equipment | $185.00K | $186.00K | $12.00K | $26.00K | $33.00K | $19.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $563.83M | $330.97M | $180.69M | $26.50M | $35.55M | $64.98M |
| Accounts payable | $12.44M | $8.88M | $3.15M | $1.78M | $3.25M | $3.49M |
| Total current liabilities | $61.36M | $18.75M | $11.51M | $7.31M | $8.01M | $8.62M |
| Long-term debt | $49.86M | $49.83M | - | - | - | - |
| Total liabilities | $113.72M | $85.86M | $23.18M | $16.15M | $17.76M | $19.43M |
| Retained earnings | -$431.37M | -$452.26M | -$276.41M | -$237.42M | -$213.35M | -$182.44M |
| Total equity | $450.12M | $245.11M | $157.51M | $10.35M | $17.79M | $45.55M |